Get all your news in one place.
100's of premium titles.
One app.
Start reading
WEKU
WEKU
Health
Leslie Walker

Legal fights and loopholes could blunt Medicare's new power to control drug prices

President Biden speaks during an event Tuesday celebrating the passage of the Inflation Reduction Act on the South Lawn of the White House. The new law gives Medicare the power to negotiate drug prices. (Anna Moneymaker/Getty Images)

On Tuesday, the White House celebrated the passage of the the Inflation Reduction Act, a sweeping climate, tax and health care package passed in August. Among other measures, it grants Medicare historic new powers to control prescription drug prices.

Democratic leaders like U.S. Sen. Chuck Schumer, D-N.Y., celebrated what they see as one of the law's historic achievements. "For years, the naysayers said we could never take on the big drug companies and lower prescription drug costs but we did, and we won," Schumer said.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.